default author photo

James H. Stark

Pfizer Biopharma Group

SCHOLARLY PAPERS

7

DOWNLOADS

281

TOTAL CITATIONS

0

Scholarly Papers (7)

1.

Estimation of the burden of Lyme borreliosis in Austria using hospital discharge data

Number of pages: 25 Posted: 06 Nov 2025
Pfizer Pharma GmbH, Pfizer, Inc., Pfizer Biopharma Group, affiliation not provided to SSRN, Pfizer, Inc., affiliation not provided to SSRN, Medical University of Vienna, University of Salzburg, Medical University of Vienna, Pfizer, Inc. and Pfizer Biopharma Group
Downloads 48 (1,121,190)

Abstract:

Loading...

Lyme borreliosis, Lyme neuroborreliosis, Lyme arthritis, Epidemiology, Incidence, Austria, medically-attended

2.

Borrelia Burgdorferi Sensu Lato Prevalence in Ixodes Scapularis from Canada: A Thirty-Year Summary and Meta-Analysis (1990-2020)

Number of pages: 32 Posted: 19 Mar 2024
Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. and Pfizer Biopharma Group
Downloads 44 (1,133,231)

Abstract:

Loading...

Lyme, Ixodes, scapularis, Borrelia, tick, surveillance, Canada, Epidemiology, Ontario, Quebec

3.

Incidence of Lyme Borreliosis in Germany: A Retrospective Observational Healthcare Claims Study

Number of pages: 24 Posted: 22 Nov 2023
Pfizer Pharma GmbH, Pfizer Pharma GmbH, Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Pfizer Biopharma Group, Pfizer Biopharma Group, Pfizer, Inc., Pfizer Biopharma Group and Brehm Memorial Center
Downloads 44 (1,133,231)

Abstract:

Loading...

Lyme borreliosis, Lyme neuroborreliosis, Lyme arthritis, epidemiology, incidence, Germany

4.

Increasing Prevalence of Borrelia Burgdorferi Sensu Lato in Ixodes Scapularis in Canada: A Meta-Analysis of Active and Passive Surveillance Studies (2000-2023)

Number of pages: 26 Posted: 26 Jan 2024
Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. and Pfizer Biopharma Group
Downloads 39 (1,196,171)

Abstract:

Loading...

Lyme, Ixodes, Borrelia, tick, surveillance, Canada

5.

Prevalence of Borrelia Burgdorferi Sensu Lato Infection in the Czech Republic

Number of pages: 34 Posted: 04 Dec 2024
Pfizer, Inc., affiliation not provided to SSRN, affiliation not provided to SSRN, National Institute of Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN, Pfizer, Inc., affiliation not provided to SSRN, Pfizer Pharma GmbH, Pfizer Biopharma Group, Pfizer, Inc. and Pfizer Biopharma Group
Downloads 37 (1,222,651)

Abstract:

Loading...

Lyme borreliosis, Lyme disease, epidemiology, disease burden, surveillance, tick-borne disease.

6.

Comparison of the Number of Lyme Neuroborreliosis Cases in European Centre for Disease Prevention and Control (ECDC) Data and National Public Surveillance Reports, 2018–2023

Number of pages: 13 Posted: 09 Jun 2025
Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., affiliation not provided to SSRN, Pfizer Pharma GmbH, Pfizer, Inc. and Pfizer Biopharma Group
Downloads 35 (1,249,711)

Abstract:

Loading...

Lyme borreliosis, neuroborreliosis, surveillance, Europe, tick-borne disease

7.

Using Meta-Analysis to Estimate the Incidence of Lyme Borreliosis Clinical Manifestations in Denmark, Ireland and Sweden Based on Publicly-Available Lyme Neuroborreliosis Data

Number of pages: 22 Posted: 14 Apr 2025
Pfizer Pharma GmbH, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., affiliation not provided to SSRN, Pfizer, Inc., Pfizer, Inc. and Pfizer Biopharma Group
Downloads 34 (1,263,436)

Abstract:

Loading...

Lyme borreliosis, Lyme neuroborreliosis, Lyme arthritis, Epidemiology, Incidence, Sweden, Denmark, Ireland